Xcell Biosciences and Culture Biosciences have entered a collaboration to integrate Culture’s cloud‑native AI and machine‑learning platform with Xcell’s AVATAR™ Foundry system - a...
Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in recombinant adeno-associated virus (rAAV) gene therapies, has established a strategic collaboration with Trogenix,...
The healthcare world is changing fast. This change is driven by something powerful yet unseen: genomics. Genomic science was once limited to labs and...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell expansion culture processes that will...
Affinia Therapeutics an innovative gene therapy company with a pipeline of rationally designed adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases,...
